CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials.

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new preventive shot against RSV, a common respiratory illness that is the leading cause of ...

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.

The CDC’s ACIP has blessed Merck’s new RSV shot Enflonsia, but the decision was not resounding from Robert F. Kennedy Jr.’s new panel of experts.

The CDC's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for respiratory syncytial virus.

Health and Human Services Secretary Robert F. Kennedy Jr.'s new panel of vaccine advisers to the Centers for Disease Control made its first decisions on Thursday. It's their first official move ...

Health Secretary Robert F. Kennedy Jr.’s newly revamped vaccine advisory panel voted on Thursday to recommend Americans receive seasonal influenza shots that are free from the mercury-based ...

HHS’ new vaccine panel backs RSV shot, rejects thimerosal in flu vaccines Advertisement By: Paige Twenter Thursday, June 26th, 2025 ...

The chair of Robert F. Kennedy Jr.'s newly constituted vaccine advisory committee announced in his first meeting that the panel will revisit the longstanding practice of vaccinating all babies ...

Another shot for RSV The members voted 5 to 2 to recommend clesrovimab for infants aged younger than 8 months born during their first RSV season who are not protected by maternal vaccination.